News and Announcements
Analytica Annual Report to Shareholders 2016
- Published October 05, 2016 4:52PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
30th September 2016, ASX Announcement
Principal activities of the Group during the yer were:
- The development of strategies on commercial sales of PeriCoach;
- The development of intellectual property of medical device and mobile health application in relation to patents and systems in the pelvic floor exercise field (PeriCoach);
- Development of intellectual property of medical device to assist neurologists and rehabilatise treatment of muscular spasticity. (ELF-2)
- The development of intellectual property in the medical device field in relation to patents in the burette field (AutoStart Infusion System);
- The development of strategies for commerical sales of burette products;
There were no significant changes in the nature of the Group’s principal activities during the year.
To view the full announcement, please click on the button below.